49
Participants
Start Date
December 3, 2012
Primary Completion Date
December 24, 2024
Study Completion Date
December 24, 2024
Bevacizumab
10mg/kg every 2weeks.
PRDR
Daily dose of 2.0gy delivered in .2gy pulses for a total of 54gy over 5.5 weeks and 27 fractions. In the rare instance of the presence of extensive disease requiring essentially whole brain radiation, a total daily dose of 1.8 Gy delivered in .2 Gy pulses for 23 fractions to a total dose of 41.4 Gy will be utilized.
University of Wisconsin Hospital and Clinics, Madison
Collaborators (1)
Genentech, Inc.
INDUSTRY
National Cancer Institute (NCI)
NIH
University of Wisconsin, Madison
OTHER